Have your own idea? Try our Stock Screener
UPDATED Dec 21, 2024
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MDXH | €3.02 | -5.6% | -52.3% | €82.4m | €7.70 | PS1.4x | E59.8% | n/a | ||
ARGX | €604.60 | 4.1% | 79.5% | €36.5b | €596.31 | PS20x | E55.7% | n/a | ||
UCB | €186.60 | 3.3% | 140.4% | €35.4b | €192.69 | PE147.5x | E33.0% | 0.7% | ||
HYL | €5.30 | -10.2% | -54.3% | €148.4m | €11.10 | PS21.4x | E-13.6% | n/a | ||
ALEMS | €0.019 | -7.0% | -13.5% | €27.7m | n/a | PB2.7x | n/a | n/a | ||
CYAD | €0.69 | -10.1% | 91.2% | €28.7m | n/a | PS398.2x | n/a | n/a | ||
TUB | €137.40 | -0.1% | 91.1% | €6.1b | €164.00 | PE67.9x | n/a | 0.7% | ||
BIOS | €0.0063 | -55.9% | -87.8% | €1.8m | n/a | PE-0.2x | n/a | n/a | ||
OXUR | €0.27 | -0.4% | -97.0% | €538.7k | n/a | PS6.4x | n/a | n/a |